Methotrexate versus expectant management in women with ectopic pregnancy
Not Applicable
Completed
- Conditions
- Ectopic pregnancyPregnancy and Childbirth
- Registration Number
- ISRCTN48210491
- Lead Sponsor
- Academic Medical Center (AMC) (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
1. All haemodynamically stable patients
2. greater than 18 years with either a suspected ectopic pregnancy (a visible ectopic pregnancy or an ectopic mass on Trans Vaginal Sonography) and a plateauing serum hCG concentration less than 1500 IU/l or with a Pregnancy of Unknown Location (PUL) and a plateauing serum hCG concentration less than 2000 IU/l (persisting PUL)
Exclusion Criteria
1. Patients with a viable ectopic pregnancy
2. Signs of tubal rupture or active intra-abdominal bleeding
3. Abnormalities in liver or renal function or in full blood count
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method